Our Clinical Research Services
ESTERN Medical provides global clinical research services to the
Biotechnology, Pharmaceutical and Medical Device industries across
Latin America.
Clinical Research Development & Regulatory
Services
Better than any other Contract Research Organization development
resource, ESTERN Medical faces and answers over Clinical R&D
and Regulatory risks with our broad knowledge solutions.
These solutions are delivered by a highly responsive team of
professionals building a customized package of services based on
your needs with our broad expertise and knowledge in Latin America.
ESTERN Medical serves in the local Latin American markets such as
Mexico, Colombia, Venezuela, Brazil, Ecuador, Peru, Chile, and
Argentina.
From early clinical development and regulatory through
late-phase clinical trials, ESTERN Medical offers the entire range
of integrated product development services you need. No matter
where your point of entry is into our resources, ESTERN Medical
will craft a customized clinical and regulatory program providing
seamless access to our full range of development services to meet
your specific needs in Latin America.
With ESTERN Medical, you can minimize your risk, optimize
development, and give your team every possible advantage in
accessing new insights and solutions. You can off-load tasks while
uploading knowledge assets and expertise.
At ESTERN Medical it's all about Results and Excellence
Our Expertise Phases I, II, III & IV in Latin America
ESTERN Medical is your development Contract Research
Organization partner through these critical phases.
ESTERN Medical helps you develop strategies to:
- Speed up development.
- Recruit the right patients more quickly into our key medical
centers partnership and strategic database for best results in your
clinical trial success. Strategically control costs.
- Ensure regulatory compliance many Latin American
countries.
- Anticipate and remove roadblocks across each country.
Your ESTERN Medical team provides:
- Superior Project Management
With a commitment to quality, our professional consulting team
ensures that your needs are met. You have a consistent, dependable
point of contact that gives you access to the entire range of
ESTERN Medical capabilities. Your team ensures that the right tools
are used in order to move you efficiently through Phases I, II, III
and IV and beyond.
- Tools for Improving Study Start-Up
With a powerful mix of patient recruitment and site management
tools, ESTERN Medical vastly improves one of the most
time-sensitive stages of any Phase I, II, III and IV studies.
Phase I
ESTERN Medical Phase I services brings together an unequalled
breadth and depth of experience and services. We offer unrivaled
expertise for safe, innovative, early-phase human drug development
to Good Clinical Practice and Good Laboratory Practice
standards.
All ESTERN Medical Phase I units combine superb healthcare and
analytical facilities with the complex amenities needed to attract,
house and motivate volunteers.
The specialized staff at each site includes physicians,
pharmaceutical scientists, nurses, investigators, analysts and
pharmacokineticists with experience in numerous therapeutic
areas.
Each unit has established its own reputation for excellence and
its own loyal client base.
ESTERN Medical is an expert in the conduct of complex,
procedurally intensive Phase I studies, ESTERN Medical provides
customized services to advance your product to the next development
phase. Our capacity to accommodate large trials combined with our
dedicated, experienced staff deliver effective integrated planning
and implementation for Phase I trials in Latin America.
Phase II & III Clinical Trials:
Our comprehensive Phase II-III experience, support systems and
global infrastructure provide the highest level of professional
program management and services to advance your product through
development and approval.
If the blockbuster potential pharmaceutical drug is there, no
one can bring it out as effectively as ESTERN Medical; Phase II and
III trials are at the heart of our business, and form the focus of
the most valuable services we offer customers. That’s because we
can bring in the heavy hitters across the board – in every medical,
business and technological specialty required to manage every
detail of a complex and fast-moving project.
Phase IV
Our strength in late stage drug development derives from
strategically aligning clinical research and marketing objectives.
ESTERN Medical’s post-approval group explores and implements a wide
range of strategies to capitalize on the strengths of your product
and maximize its life cycle.
Safety continues to be a key issue for both physicians and
patients. More than ever before, scientists, researchers and
Biotech, Pharmaceutical & Medical Device companies like yours
recognize that expanding safety initiatives is not simply an
option, but a necessity. Your continued success is dependent upon
developing therapies that have a strong track record when it comes
to patient safety.
ESTERN Medical understands your commitment to patient safety and
offers our Safety Solution Center. We will work with you to expand
safety initiatives and will help you anticipate, and prepare for
critical issues that may arise in your development.
The Guiding Principles in the Regulatory Affairs Steps for
Latin America.
At ESTERN Medical, our regulatory and safety guidance oversight
services are a seamless part of the drug development process from
beginning to end.
Our regulatory have broad track record experience and a rapport
with many Latin American regulatory agency divisions, that let us
explore options with customers to succeed shortest route of their
clinical trials and timeframe to bring their products to
market.
It’s about having experience with the Latin American, FDA and
the European regulatory authorities, so we can explore with you the
most efficient route and shortest timeframe to market. It’s
therapeutic area expertise. It’s understanding regulations, such as
Common Technical Document (CTD) requirements or the European
Clinical Trial Directive.
We know what issues are likely to come up and can develop
strategies to address them early on. In addition, our knowledge of
local market requirements throughout Latin American countries and
specific regions in Latin America gives you the advantage of
submitting registration applications simultaneously in any regions
that interest you.
We begin with a strategic regulatory, scientific, and safety
planning in the clinical trial phase that you will be launching.
And collaborate in the designing a study that integrates a full
understanding of the current regulations and the regulatory
environment from the start to completion of your study, we can help
you ensure that the complete drug development process will run more
smoothly and efficiently.
ESTERN Medical also provides Business Science coordination and
of clinical and post-marketing studies throughout Latin
America.
IRB’s Independent Institutional Review Board in Latin
America
ESTERN Medical provides you with guidance over independent
ethical review of your drug and/or device trials when review of
protocols for the protection of human research subjects by an
on-site board is not available across Latin America.
Independent IRB across Latin America has provided this service
to a growing national clientele of investigators and sponsors.
ESTERN Medical IRB guidance provides independent ethical review
of your drug and/or device trials when review of protocols for the
protection of human research.
The Independent IRB operates in compliance with federal
regulations governing Institutional Review Boards set forth in 21
CFR Part 56, federal regulations governing informed consent set
forth in 21 CFR Part 50, as well as ICH guidelines for good
clinical practices. The Independent IRB can review studies for a
single investigator or serve as a central IRB for multi-center
trials across Latin America.
Confidentiality
The confidentiality of information contained in the documents
submitted to the Independent IRB is carefully preserved. Protocols,
investigator drug brochures, informed consent documents, IND’s,
NDA’s, PMA’s IDE’s 510K’s safety reports, and other records are
safeguarded in locked files, with access strictly limited to the
IRB staff. In addition, each Board member signs an agreement to
treat all reviewed material as confidential.
The overriding objective is to ensure that the privacy of
individuals, industries and institutions involved in the protocol
is respected.
Meeting Schedule
The IRB meetings are usually twice a month during the year.
Specific meeting dates can be provided upon request. In addition to
the schedule above, ad hoc sessions are convened to meet a
client's special needs.
Turn-Around Time
The protocol, IDB, informed consent, and any proposed
advertising should be submitted to the IRB no later than one week
before the next scheduled IRB meeting. After review by the board,
the investigator and/or sponsor will be notified of the outcome
within 24 hours. Expedited reviews are handled within 24-48
hours.
Quick IRB Review
The IRB meets twice a month or special meetings can be arranged.
Approval letter for full-board review items are sent approximately
48-72 hours after the IRB meeting, and expedited review items are
sent approximately 24-48 hours from their submission.
Latin America Patient Recruitment
Latin America Clinical Trials Recruitment
ESTERN Medical significantly impacts the drug development
timeline by accelerating the process of recruiting and enrolling
patients into clinical trials in Latin America.
ESTERN Medical attributes its recruitment success story in
recruitment due to the broad variety of novel diseases and
age-related chronic diseases, with patients largely unexposed to
previous treatments and a wide population: 552,296,094 people
across 20 countries Latin America.
Therefore one of our main objectives is to keep trials on
schedule - or even ahead of schedule.
ESTERN Medical is increasingly leveraging its reach and
knowledge in Latin America. More and more customers are discovering
the advantages of conducting trials in the diverse non-traditional
regions of the world, where patient populations, well-trained
investigators and high-quality communications systems are readily
available - and where ESTERN Medical has years of experience and
expertise mastering local disease profiles, customs and
regulations. By putting it all together, we deliver speedy study
start-up consulting and top quality results that meet FDA and ICH
GCP standards.
Expanded reach, easier access to specific diverse patient
populations in Latin America Different therapeutic indications tend
to cluster in different regions of the world. ESTERN Medical
consulting and teams work in non-traditional regions and include
physician specialists in key therapeutic areas to help fine-tune
study designs and protocols.
Patients in non-traditional regions such as Latin America have a
high rate of protocol compliance and low dropout rates because of
the high standards of medical care available through clinical
trials.
This and the combination of our reach and local knowledge in
Latin America can result in speedy recruitment of specific patient
populations.
ESTERN Medical Patient Recruitment Data Base in Latin
America Patients Recruitment
ESTERN Medical significantly impacts the drug development
timeline by accelerating the process of recruiting and enrolling
patients into clinical trials across our Latin America Medical
Centers in which we have a partnership and track record of success
in diverse clinical trials phases. ESTERN Medical has the solutions
to help and guide you over our state of the art recruitment
database.
ESTERN Medical database provides Biotech, Pharmaceutical and
Medical Device Companies patient enrollment solutions for clinical
trials.
ESTERN Medical offers customized single-source, full-service
solutions that leverage the most cost-efficient and effective
outreach, screening, and clinical site support methods for each
individual trial.
Broaden the pool of high-quality, pre-screened patients.
Accelerate the patient recruitment process.
Increase the throughput of patients during the enrollment
process.
Our Patient Recruitment Solutions for Sponsors
The primary reasons clinical trials fall behind
are:
Patients are unaware of study opportunities.
It is difficult to motivate patients to switch from
an already-existing therapy.
Competing protocols mean there are only a limited
number of patients available to participate in studies.
There is poor planning regarding study
start-up.
By accessing ESTERN Medical data base expertise and
combining services on recruitment and informatics data, sponsors
can ensure success.
Patient Recruitment
ESTERN Medical employs the print and broadcast media to reach a
diverse population.
ESTERN Medical produces the recruitment messages and manages
media planning, placement, and monitoring for TV and radio for
clinical trials in Latin America.
Sponsors can provide a dramatic reduction in recruitment
timelines by combining our broadcast-based recruitment with our
call center services.
Patient Recruitment Solutions for Investigators
ESTERN Medical recognizes the importance of the clinical
investigator in the patient recruitment process. We offer
customized consulting services to help investigators streamline the
patient recruitment, screening, and enrollment process.